TOI Earnings

TOI reported its earnings on 2026-05-07, showcasing a revenue of 147.44M against an estimate of 145.20M, resulting in a 1.54% surprise. The EPS was -0.02, surpassing the expected -0.07 by 71.43%. The stock experienced a -1.72% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TOI's earnings announcement on 2026-05-07, the stock price moved by -1.72% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, TOI's stock price tends to shift by an average of 3.8% in the 10 days leading up to earnings and -8.17% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate TOI's annual revenue to reach 150.58M, while the EPS is projected at -0.09. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TOI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TOI's stock price typically moves by 3.8% in the 10 days before its earnings and -8.17% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.09 and revenue of 150.58M.

The earnings call demonstrates strong financial performance with improved MLR and profitability in Florida, positive growth in dispensary attachment rates, and significant free cash flow improvements. The Q&A reveals optimism about expanding health plan agreements and leveraging pharmacy networks. Although management was vague about specific health plans, the overall sentiment remains positive due to the company’s strategic growth and profitability in key markets. Despite the lack of market cap data, the positive financial and strategic developments suggest a likely stock price increase.